Altria Group, Inc. (BCBA:MO)
Argentina · Delayed Price · Currency is ARS | Market Cap | 174.51T +8.6% |
| Revenue (ttm) | 30.29T +0.9% |
| Net Income | 11.78T -9.3% |
| EPS | 7,031.27 -8.2% |
| Shares Out | n/a |
| PE Ratio | 14.81 |
| Forward PE | 11.98 |
| Dividend | 995.80 (3.61%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Volume | 7,651 |
| Open | 27,580 |
| Previous Close | 27,480 |
| Day's Range | 27,460 - 27,860 |
| 52-Week Range | 20,360 - 30,860 |
| Beta | 0.49 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |
About Altria Group
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. It offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. The company sells its products to distributors, as well as large retail organizations, such as chain stores. ... [Read more]
Financial Performance
In 2025, Altria Group's revenue was $20.14 billion, a decrease of -1.49% compared to the previous year's $20.44 billion. Earnings were $6.93 billion, a decrease of -38.35%.
Financial numbers in USD Financial StatementsNews
US FDA plans move to speed up vape, pouch approvals, WSJ reports
The U.S. Food and Drug Administration is expected to unveil measures in the coming days that would speed up approvals for vaping products and nicotine pouches, the Wall Street Journal reported on We...
Altria Stock (MO) Gains After Suing the FDA over Nicotine Product Reviews
Shares of Altria ($MO) are up at the time of writing after the tobacco giant sued the U.S. Food and Drug Administration over how the agency reviews new nicotine products.
Altria sues US FDA, court records show
Marlboro-maker Altria sued the U.S. Food and Drug Administration on Wednesday, court records show.
Juul Labs Gets FDA Authorization to Sell New E-Cigarette
The privately held vapor company said its updated vaping device, the Juul2, offers what it's calling a more consistent vapor and nicotine delivery experience, and is designed to compete effectively wi...
FDA allows marketing of Juul's new e-cigarettes and flavored pods
The U.S. Food and Drug Administration on Friday authorized the marketing of three new 'JUUL2' e-cigarette products, the latest in a series of approvals for nicotine products the agency says may offe...
Altria Group announces Presley joined our Board of Directors
Altria Group (MO) announces that Steven Presley joined our Board of Directors on August 27, 2026. Presley is Chief Executive Officer of Refresco Benelux B.V.
Altria Announces Election of Steve Presley to Altria's Board of Directors
RICHMOND, Va.--(BUSINESS WIRE)---- $MO #Altria--Altria Announces Election of Steve Presley to Altria's Board of Directors.
Altria Group raises quarterly dividend 4.7% to $1.11 per share
Altria Group (MO) announced that its Board of Directors voted to increase its regular quarterly dividend by 4.7% to $1.11 per share versus the previous rate of $1.06 per share.
Altria Increases Quarterly Dividend to $1.11 Per Share
RICHMOND, Va.--(BUSINESS WIRE)---- $MO #Altria--Altria Increases Quarterly Dividend to $1.11 Per Share.
Altria, Philip Morris International sign contract manufacturing deals
Philip Morris International and Altria said on Monday they had entered contract manufacturing arrangements with one another, as Altria looks to grow cigarette imports and exports and take advantage ...
Altria announces arrangement with Philip Morris to enhance efficiency
Altria Group (MO) announced that Philip Morris USA has entered into a contract manufacturing arrangement with non-U.S. affiliates of Philip Morris International (PM) that is intended to enhance the ef...
Philip Morris International Announces Contract Manufacturing Collaboration with Altria
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) today announced that it has entered, through its non-U.S. affiliates, into a contract manufacturing ar...
Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency
RICHMOND, Va.--(BUSINESS WIRE)--Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency.
MO Investors Have Opportunity to Join Altria Group, Inc. Fraud Investigation with SBS Law
LOS ANGELES, Aug. 24, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Altr...
Altria Group price target lowered to $58 from $64 at Barclays
Barclays lowered the firm’s price target on Altria Group (MO) to $58 from $64 and keeps an Underweight rating on the shares. The firm updated models in the tobacco industry,…
Altria Group Earnings Call Transcript: Q2 2026
Second quarter and first half results showed strong adjusted EPS and OCI growth, with robust performance in smokable and oral segments, increased shareholder returns, and improved regulatory clarity. Guidance for 2026 EPS was raised, while consumer and macroeconomic pressures remain key watchpoints.
Altria Group Earnings release: Q2 2026
Altria Group released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Altria Group Quarterly report: Q2 2026
Altria Group has published its Q2 2026 quarterly earnings report on July 30, 2026.
Altria Group Slides: Q2 2026
Altria Group has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Altria Profit Falls on Softer Oral-Tobacco Performance
Altria Group had virtually flat revenue and lower profit in the second quarter, as lower sales of its nicotine pouches offset some of the growth in its cigarettes business.
Altria Group reports Q2 adjusted EPS $1.48, consensus $1.50
Reports Q2 revenue $6.1B, consensus $5.35B. Revenues net of excise taxes $5.4B. “In the second quarter, our operating companies continued to deliver against the priorities we outlined at the start…
Altria Group narrows FY26 adjusted EPS view to $5.61-$5.72 from $5.56-$5.72
Consensus $5.69. The company said, “We narrow our guidance for 2026 full-year adjusted diluted EPS to be in a range of $5.61 to $5.72, representing a growth rate of 3.5%…
Altria Reports 2026 Second-Quarter and First-Half Results; Narrows 2026 Full-Year Earnings Guidance
RICHMOND, Va.--(BUSINESS WIRE)---- $MO #Altria--Altria Reports 2026 Second-Quarter and First-Half Results; Narrows 2026 Full-Year Earnings Guidance.